1.74 Hemab Therapeutics Announces $135M Series B Financing to Advance First Prophylactic Treatments for Underserved Bleeding and Thrombotic Disorders

<< vissza

Hemab Therapeutics Announces $135M Series B Financing to Advance First Prophylactic Treatments for Underserved Bleeding and Thrombotic Disorders
Dátum: 2023-02-21 [news.yahoo.com]

A TELJES HÍR ELOLVASÁSA >>
×